关于公司
- 法定名称: Samchundang Pharm. Co., Ltd
- 注册国家: Republic of Korea
- 地址: 71, Jeyakgongdan2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
- 员工人数: 250 - 499
描述:
SamChunDang Pharm Co., Ltd. is a top Korean pharmaceutical company specializing in ophthalmic products, holding US and EU GMP certifications that position it as a leader in generic ophthalmic production. Its groundbreaking work includes developing a biosimilar for Eylea (Aflibercept), a macular degeneration treatment, earning industry recognition; SCD's vision extends beyond ophthalmology as it expands into non-ophthalmic fields including new drug delivery systems, oral GLP-1 and long-acting injections, aiming to revolutionize the global pharmaceutical industry.
业务活动
成品制剂
制造商
生物制药产品
制造商
原研原料药
制造商
主要产品/服务
- 成品制剂: Sodium hyaluronate 0.1%, 0.18%, 0.3% Eye Drops (multi/mono dose), Olopatadine 0.1%, 0.2% Eye Drops, Latanoprost preservative-free Eye Drops (mono dose), Moxista Eye drops(Multi/Single Dose), Oloten Eye Drops(Multi/Single dose), Olotenplus Eye Drops(Multi/Single Dose), Tolon Eye Drops(Multi/Single Dose), Sodium Hyaluronate 0.15% Eye Drops(Multi/Single Dose), IrisPlus Eye Drops (disposable)
- 生物制药产品: Eylea biosimilar vial & PFS
- 原研原料药: Brimonidne/Timolol Eye Drops
我们的产品与服务
Sell · Finished Dosage Forms
Certifications
FDA
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论